Bombardieri S, Vitali C, Caponi L, Manca L, Bencivelli W
Clinical Immunology Unit, Istituto di Patologia Medica dell'Università di Pisa, Italy.
Clin Exp Rheumatol. 1994 Nov-Dec;12 Suppl 11:S45-8.
Several clinical indices have been proposed to measure disease activity in systemic lupus erythematosus (SLE), a disorder characterised by alternate phases of flare and remission. Over the last 5 years a European multicenter study was carried out in order to reach a consensus on the definition of SLE activity. A new index, ECLAM (European Consensus Lupus Activity Measurement), was created and then validated in the first and in the second parts of the study, respectively. In addition, a comparison between ECLAM and the other most commonly used lupus activity indices was performed. ECLAM appeared to be the best activity index for classifying lupus patients, whether used as a single state index (i.e., to measure activity at a given moment in time) or as a transition index. (i.e., to measure variations in activity over time).
已有多项临床指标被提出用于衡量系统性红斑狼疮(SLE)的疾病活动度,这是一种以病情发作和缓解交替为特征的疾病。在过去5年里,开展了一项欧洲多中心研究,旨在就SLE活动度的定义达成共识。创建了一个新的指标ECLAM(欧洲狼疮活动度共识测量指标),并分别在该研究的第一部分和第二部分进行了验证。此外,还对ECLAM与其他最常用的狼疮活动度指标进行了比较。ECLAM似乎是对狼疮患者进行分类的最佳活动度指标,无论是用作单一状态指标(即测量某一特定时刻的活动度)还是用作转换指标(即测量随时间变化的活动度)。